Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: SurModics

Market Cap 427M 371M 342M 320M 598M 40.92B 611M 4.08B 1.58B 19.72B 1.6B 1.57B 68.58B P/E Ratio 2023
-292x
P/E Ratio 2024 -47.3x
Enterprise Value 420M 365M 336M 315M 589M 40.26B 601M 4.01B 1.55B 19.41B 1.58B 1.54B 67.48B EV / Sales 2023
3.33x
EV / Sales 2024 4.33x
Free-Float
99.63%
Yield 2023 *
-
Yield 2024 -
1 year 25.87
Extreme 25.87
43
3 years 22.15
Extreme 22.15
43
5 years 16
Extreme 16
62.27
10 years 16
Extreme 16
82.35
Manager TitleAgeSince
Chief Executive Officer 67 19/11/2025
Director of Finance/CFO 53 19/11/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 67 19/11/2025
Director/Board Member 53 19/11/2025
Date Insider Type Main position Quantity % Market Cap.
11-19Issuer sale

Chairman

61,368 0.4292%
11-19Issuer sale

Chief Financial Officer

184,019 1.2871%
11-19Issuer sale

Executive/Senior Manager

152,074 1.0636%
Change 5-day change 1-year change 3-year change Capi.($)
+0.35%-.--%+47.19%+92.05% 615M
+0.54%+3.06%-33.16%-11.84% 155B
+0.10%+3.05%-8.67%-4.06% 103B
+0.09%+6.77%-0.97%+57.94% 54.72B
-0.23%-6.71%+50.66%+49.87% 53.65B
-0.30%+1.19%-15.51%-41.41% 40.72B
+1.61%+7.72% - - 30.9B
+0.64%+3.41%-11.28%-39.48% 28.85B
-0.18%+4.44%+45.08%-5.15% 23.38B
-1.93%-0.66%-14.31%+2.17% 21.22B
Average +0.09%+2.33%+6.56%+11.12% 51.24B
Weighted average by Cap. +0.45%+2.29%-7.39%+1.55%

Financials

2023 2024
Net sales 133M 115M 106M 99.38M 186M 12.7B 190M 1.27B 490M 6.12B 498M 487M 21.28B 126M 109M 101M 94.5M 177M 12.07B 180M 1.2B 466M 5.82B 473M 463M 20.23B
Net income -1.54M -1.33M -1.23M -1.15M -2.15M -147M -2.2M -14.66M -5.67M -70.89M -5.77M -5.64M -247M -11.54M -10.02M -9.23M -8.65M -16.16M -1.11B -16.5M -110M -42.64M -533M -43.33M -42.39M -1.85B
Net Debt -12.1M -10.5M -9.68M -9.07M -16.95M -1.16B -17.3M -115M -44.71M -559M -45.43M -44.45M -1.94B -6.87M -5.96M -5.5M -5.15M -9.62M -658M -9.82M -65.55M -25.38M -317M -25.79M -25.23M -1.1B
Logo SurModics
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Employees
389
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. SRDX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!